生物技术与制药领域的最新动态
Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire
Lonza Expands TheraPEAK® Portfolio to Strengthen Support for Gene and Cell Therapy Development - Lab Manager
Lonza Expands Cell and Gene Therapy Portfolio - Contract Pharma
Lonza Announces Innovation Day at SupplySide Global - WholeFoods Magazine
Lonza announces new board nominee - The Vacaville Reporter
Lonza’s Synaffix Collaborates with Qurient Therapeutics on Dual-Payload ADC Development - GEN - Genetic Engineering and Biotechnology News
Lonza’s Synaffix and Qurient team up on dual-payload ADC - The Pharma Letter
RION engages Lonza to scale manufacturing exosome based therapeutics - News-Medical
Lonza's Synaffix Collaborates with Qurient Therapeutics to Enable Development of Dual-Payload ADC - Yahoo Finance
RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics - Business Wire
RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing - Contract Pharma
Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics - GEN - Genetic Engineering and Biotechnology News
Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now - Nasdaq
Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Jessup Lonza Club serves up first Lonza competition - fox56.com
Jason Berndt ’01 Joins Lonza as New Head of Group Operations, Executive VP - West Point Association of Graduates
Lonza Group AG's (VTX:LONN) 3.4% loss last week hit both individual investors who own 50% as well as institutions - Yahoo Finance
Lonza Appoints Jason Berndt as Head of Group Operations - Contract Pharma
Top 10 Contract Development and Manufacturing Organizations 2025 - GEN - Genetic Engineering and Biotechnology News
Lonza’s UC-II Collagen earns NutraStrong certification, backed by clinical evidence on knee flexibility - Nutritional Outlook